[
    {
        "question": "In enzyme-based drug design, the drug binds to the enzyme active site. Based on the concept, which of the following statements is correct?",
        "type": "multiple_choice",
        "answers": [
            {
                "answer": "When the endogenous ligand is bound in the enzyme cavity, the drug cannot bind with enzyme.",
                "correct": false,
                "feedback": "Incorrect"
            },
            {
                "answer": "The drug designed competitively binds to the active site and inhibits endogenous ligand binding to the enzyme.",
                "correct": true,
                "feedback": "Correct"
            },
            {
                "answer": "Both drug and endogenous ligand bind to the enzyme, but enzyme activity is reduced",
                "correct": false,
                "feedback": "Incorrect"
            },
            {
                "answer": "Enzyme active site and drug binding site on the enzyme are different.",
                "correct": false,
                "feedback": "Incorrect"
            }                  
        ] 
    }
]